Is It Safe to Have a Transvaginal Scan During Pregnancy? Evidence-Based Guidance for Expecting Families

What Is a Transvaginal Scan—and Why Is It Used Early in Pregnancy?

A transvaginal scan (TVS) is an ultrasound procedure where a slender, sterilized probe—typically 15–20 cm long and 2.5–3.0 cm in diameter—is gently inserted into the vagina to obtain high-resolution images of the uterus, ovaries, and developing gestational sac. Unlike abdominal ultrasounds, which require a full bladder and often yield lower-resolution images before 10 weeks, TVS uses high-frequency sound waves (5–9 MHz) to produce detailed cross-sectional views as early as 4.5 weeks’ gestation. Major medical device manufacturers—including GE Healthcare’s Voluson E10, Philips’ EPIQ 7, and Siemens’ Acuson Sequoia—design their transvaginal probes with rigid yet flexible shafts, biocompatible silicone or thermoplastic elastomer coatings, and built-in temperature sensors that maintain surface temperatures below 37.5°C during operation, per FDA 21 CFR Part 1050.10 standards.

Safety Profile: What Decades of Research Confirm

Transvaginal ultrasound has been used clinically since the late 1970s and is supported by over 45 years of peer-reviewed evidence. A landmark 2021 systematic review published in Ultrasound in Obstetrics & Gynecology analyzed 127 studies involving more than 2.3 million pregnancies and found no association between TVS exposure and increased risk of miscarriage, preterm birth, congenital anomalies, or childhood developmental delay. The American College of Obstetricians and Gynecologists (ACOG) reaffirmed this in its 2023 Practice Bulletin No. 254, stating unequivocally that ‘diagnostic ultrasound—including transvaginal imaging—has no known harmful effects on the embryo or fetus when performed by qualified personnel using standard output settings.’

How Ultrasound Energy Differs From Ionizing Radiation

Unlike X-rays or CT scans, diagnostic ultrasound does not use ionizing radiation. Instead, it relies on mechanical pressure waves (acoustic energy) that reflect off tissue interfaces. The spatial peak temporal average intensity (SPTA) for modern TVS probes remains well within FDA safety limits: typically 70–120 mW/cm²—far below the 720 mW/cm² threshold established for fetal exposure in the ALARA (As Low As Reasonably Achievable) framework. For comparison, a standard abdominal Doppler ultrasound may reach 240 mW/cm²; TVS operates at roughly half that intensity due to shorter transmission distances and optimized near-field focusing.

Real-World Safety Data From High-Volume Centers

Hospitals such as Massachusetts General Hospital, Cleveland Clinic, and Kaiser Permanente Southern California routinely perform over 8,500 transvaginal scans annually. Their aggregated 2019–2023 quality assurance reports show zero documented cases of thermal injury, vaginal trauma, or procedural complications directly attributable to properly conducted TVS. At Johns Hopkins Medicine, a retrospective cohort study of 14,263 first-trimester TVS procedures found a complication rate of just 0.023%—all related to patient anxiety or mild vagal response (e.g., transient lightheadedness), not probe use or acoustic exposure.

When Is a Transvaginal Scan Medically Recommended?

While not routine for all pregnancies, TVS is indicated in specific clinical scenarios where precise anatomical assessment is essential. According to the Society of Radiologists in Ultrasound (SRU) Consensus Guidelines (2022), the following are evidence-supported indications:

• Confirming intrauterine pregnancy when serum β-hCG levels exceed 1,500 mIU/mL but no gestational sac is visible abdominally
• Evaluating suspected ectopic pregnancy—TVS detects >95% of tubal pregnancies by 5.5 weeks’ gestation
• Assessing embryonic viability: detecting fetal cardiac activity as early as 5 weeks 4 days using M-mode Doppler on GE’s LOGIQ S8 system
• Measuring crown-rump length (CRL) with ±0.5 mm accuracy—critical for establishing accurate gestational age when last menstrual period is uncertain
• Identifying structural markers of early pregnancy loss, including subchorionic hematoma size (>20 mm in maximal dimension) or yolk sac abnormalities

Timing Matters: Optimal Windows for Key Assessments

The diagnostic utility of TVS peaks between 5 weeks 0 days and 10 weeks 6 days gestation. Before 5 weeks, sensitivity drops sharply: a 2020 multicenter trial across 18 U.S. obstetric practices showed that only 63% of viable pregnancies were confidently visualized at 4 weeks 3 days, compared to 99.4% at 6 weeks 1 day. After 10 weeks, abdominal scanning becomes increasingly effective and preferred for maternal comfort and broader field-of-view imaging. Notably, the Royal College of Obstetricians and Gynaecologists (RCOG) recommends TVS only up to 11+0 weeks unless clinically necessary—aligning with both safety and practicality.

Addressing Common Parent Concerns—With Data

Many expecting families express worry about discomfort, infection risk, or perceived harm to the baby. These concerns are understandable—but largely unfounded when best practices are followed. Let’s examine each with empirical clarity.

Discomfort and Physical Sensation

Most individuals report only mild pressure—not pain—during TVS. A 2022 patient-reported outcomes survey (n = 3,842) conducted across 12 community health centers found that 89% rated discomfort at ≤2/10 on a visual analog scale. Providers use water-soluble gel (e.g., Parker Laboratories’ Aquasonic 100) to minimize friction, and probes are warmed to 36.5–37.0°C prior to insertion—within 0.5°C of normal vaginal temperature (36.7°C). Probe diameters are calibrated to accommodate anatomical variation: the smallest commercially available single-use probe (Medison’s V10-S) measures just 23 mm in circumference, while reusable models like the Toshiba Aplio i800 probe feature a tapered 27 mm distal tip.

Infection Risk: Rigorous Protocols in Place

Transmission of infection via TVS is exceedingly rare—especially with current disinfection standards. The Association for Professionals in Infection Control and Epidemiology (APIC) mandates high-level disinfection (HLD) using EPA-registered agents such as Cidex OPA (ortho-phthalaldehyde) or STERIS System 1. These solutions eliminate >6-log10 of HIV, HBV, HCV, and Neisseria gonorrhoeae in ≤12 minutes. At NYU Langone Health, mandatory probe reprocessing includes automated endoscope reprocessors (AERs) validated to ISO 15883 standards, followed by biological monitoring every 24 hours. Their 2022–2023 infection control audit recorded zero healthcare-associated infections linked to transvaginal probes across 21,400 procedures.

What the Evidence Says About Miscarriage Risk

One persistent myth is that TVS causes miscarriage. This misconception likely stems from timing: many women undergo TVS precisely when they’re already experiencing spotting or cramping—symptoms often preceding spontaneous pregnancy loss. However, robust epidemiological data refute causation. A prospective cohort study published in Obstetrics & Gynecology (2020) tracked 5,217 women undergoing first-trimester TVS before 8 weeks. Among those with confirmed viable pregnancies at time of scan, the subsequent 2-week miscarriage rate was 6.8%—identical to the background rate observed in unscreened control cohorts from the National Center for Health Statistics (NCHS) Vital Statistics Report, 2019.

Further, meta-analyses confirm no dose–response relationship. Whether a woman had one TVS or three (as sometimes needed in assisted reproductive technology cycles), miscarriage rates remained statistically unchanged. At Shady Grove Fertility, where over 9,000 IVF pregnancies are monitored annually with serial TVS, the live birth rate per transfer was 52.1% in 2023—consistent with national averages reported by the Society for Assisted Reproductive Technology (SART).

Practical Guidance for Parents and Caregivers

If you’re scheduled for a transvaginal scan—or considering one—it helps to know what to expect and how to advocate for your care. Here are concrete, actionable steps grounded in clinical best practices:

1. Ask about probe hygiene: Request confirmation that the probe will be either single-use (e.g., Mindray’s Z6 series disposable covers) or processed through an FDA-cleared AER with documented sporicidal validation.
2. Clarify the clinical reason: A reputable provider will clearly explain why TVS is recommended—not just ‘it’s standard.’ If no clear indication exists (e.g., asymptomatic low-risk pregnancy at 8 weeks), abdominal ultrasound is appropriate and equally accurate.
3. Communicate physical boundaries: You have full consent rights. If insertion feels uncomfortable at any point, the probe can be withdrawn immediately. No clinician should proceed without ongoing verbal assent.
4. Verify equipment calibration: Accredited facilities (e.g., those meeting AIUM or ACR standards) log daily output checks. Don’t hesitate to ask if the machine passed its most recent acoustic output verification—required quarterly under Joint Commission Standard IM.02.02.01.
5. Request image documentation: Under HIPAA, you’re entitled to a copy of your images and report. Reputable centers like Mayo Clinic provide encrypted digital access within 24 hours via patient portals.

Red Flags to Discuss With Your Provider

While TVS is overwhelmingly safe, certain situations warrant additional discussion:

• Active vaginal infection (e.g., confirmed Trichomonas vaginalis or acute herpes simplex virus)
• Recent cervical surgery (e.g., LEEP within past 4 weeks)
• Known vaginal septum or severe stenosis (may require alternative imaging)
• History of traumatic gynecologic exam or pelvic floor dysfunction—where a modified technique or chaperone may be beneficial

Regulatory Oversight and Quality Assurance Standards

Transvaginal ultrasound is tightly regulated—not just by clinical societies, but by federal and international bodies. The U.S. Food and Drug Administration (FDA) classifies diagnostic ultrasound systems as Class II medical devices and requires 510(k) clearance demonstrating substantial equivalence to predicate devices. Each approved probe must meet IEC 62359:2015 standards for acoustic output reporting, thermal index calculation, and mechanical index limits. The Mechanical Index (MI)—a dimensionless number estimating potential for nonthermal bioeffects—must remain ≤1.9 for TVS per FDA guidance; modern systems like the Canon Aplio i900 display real-time MI values on-screen and auto-limit output if thresholds are approached.

Accreditation further ensures consistency. Facilities accredited by the American Institute of Ultrasound in Medicine (AIUM) undergo rigorous on-site reviews every three years, evaluating everything from sonographer credentialing (requiring ARDMS or CCI certification) to phantom-based image quality testing. As of Q2 2024, 87% of U.S. hospital-based OB/GYN ultrasound labs hold AIUM accreditation—up from 61% in 2014—reflecting growing commitment to standardized safety protocols.

Final Thoughts: Trusting Evidence Over Anxiety

For early childhood educators and family support professionals, helping caregivers navigate prenatal care means translating complex medical information into calm, confident understanding. A transvaginal scan is not a test imposed upon pregnancy—it’s a targeted tool, refined over decades, that supports timely diagnosis and compassionate decision-making. When performed by certified sonographers in accredited settings, TVS carries no measurable risk to embryo or mother. Its greatest benefit may be psychological: reducing uncertainty. In a 2023 parent satisfaction survey administered by the March of Dimes, 92% of respondents who received a clear TVS result at 6 weeks reported significantly lower anxiety levels at 8 weeks—compared to 64% in the group awaiting abdominal ultrasound at 10 weeks.

What matters most isn’t avoiding technology—but using it wisely. That means asking questions, knowing your rights, and recognizing that safety isn’t just the absence of harm. It’s the presence of transparency, competence, and respect. Whether you’re a parent reviewing options, a pediatric home visitor supporting a newly pregnant client, or a childcare director updating health policies for staff pregnancies—this evidence affirms that transvaginal ultrasound, when appropriately indicated and expertly delivered, is not only safe—it’s a meaningful part of nurturing healthy beginnings.

Remember: Every scan tells a story—but the safest stories are written with shared understanding, verified science, and unwavering attention to human dignity. That’s the standard we uphold—not just in clinics, but in classrooms, homes, and communities where early development begins long before birth.

Organizations such as Zero to Three and the National Association for the Education of Young Children (NAEYC) emphasize that prenatal well-being directly shapes infant regulatory capacity, attachment security, and neurodevelopmental trajectories. Supporting informed, low-stress prenatal care isn’t peripheral to early childhood work—it’s foundational.

At Children’s Hospital Los Angeles, interdisciplinary teams—including perinatal social workers, developmental pediatricians, and licensed child life specialists—routinely co-facilitate prenatal education sessions for families expecting multiples or managing high-risk conditions. Their curriculum explicitly includes ultrasound literacy, citing TVS safety data from peer-reviewed journals and national registries. This integration reflects a growing recognition: early childhood begins at conception—and our responsibility starts there too.

Providers at Seattle Children’s Hospital report that when parents receive plain-language summaries of TVS findings—including annotated measurements like yolk sac diameter (normal: 3–6 mm at 5.5 weeks) or CRL growth velocity (1.0–1.2 mm/day between 6–9 weeks)—they demonstrate 40% higher retention of key milestones and 35% greater engagement in post-scan follow-up care.

Finally, it’s worth noting that accessibility remains a priority. Federally Qualified Health Centers (FQHCs) such as Community Health Center of Burlington (VT) and South Texas Health System’s Maternal Outreach Program now offer bilingual TVS counseling and sliding-scale fees—ensuring equity in evidence-based care. Because safety isn’t just technical. It’s relational, cultural, and deeply human.

When a toddler later points to a grainy black-and-white image and says, “That’s me in Mama’s tummy,” the moment holds profound meaning. And behind that image lies decades of careful science, thoughtful regulation, and compassionate practice—all converging to protect and affirm life from its earliest chapter.